Business
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical technologiesExpansion of commercial team reflects increasing demand for Nociscan, supported by triple-digit growth in utilization BROOMFIELD, Colo., April 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algori
About this update from Aclarion, Inc.
[{"type":"image","alt":"Aclarion, Inc.","displaySize":"","headline":null,"caption":"Aclarion, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":140,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EohHW56rTadgndYE9QH9_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNQ--/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical technologies","length":148,"tagName":"p"}]},{"val":[{"type":"text","content":"Expansion of commercial team reflects increasing demand for Nociscan, supported by triple-digit growth in utilization","length":117,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":265,"olType":false},{"type":"text","content":"BROOMFIELD, Colo., April 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the appointment of Daniel Keefe as Commercial Director, Western U.S.","length":390,"tagName":"p"},{"type":"text","content":"Dan will lead commercial efforts across the Western region, building on Aclarion’s existing footprint and supporting continued adoption of Nociscan. Aclarion has established a growing presence across the Western U.S., with engagement spanning both academic institutions and high-volume private practice spine centers, supported by strong volume growth. Dan’s appointment reflects the Company’s focus on expanding this momentum and deepening adoption in a key strategic region.","length":476,"tagName":"p"},{"type":"text","content":"“Dan brings a proven track record of driving commercial growth and expanding adoption of innovative surgical technologies,” said Brent Ness, Chief Executive Officer of Aclarion. “His deep experience working with spine surgeons and hospital systems, combined with his ability to build and scale high-performing territories, will be instrumental as we continue to grow our presence in the Western U...